Related Experiment Videos
Recombinant adenoviruses as vaccines
V Randrianarison-Jewtoukoff1, M Perricaudet
1Unité de Génétique des Virus Oncogénes, CNRS URA 1301, Institut Gustave Roussy, Villejuif, France.
Summary
Adenovirus (Ad) vectors show promise for gene therapy and vaccine development due to efficient gene transfer. However, challenges remain for their application in preventive medicine.
Area of Science:
- Molecular biology
- Gene therapy
- Vaccinology
Background:
- Advances in molecular biology enable in vitro and in vivo gene transfer into mammalian cells.
- Genetically engineered microorganisms offer potential for gene therapy and vaccine development.
- Various vector systems exist, each with specific advantages and limitations.
Purpose of the Study:
- To review the potential of Adenovirus (Ad) as a vaccine vector.
- To discuss the applications of Ad vectors in gene therapy and induced immunity.
- To identify obstacles related to the use of Ad in preventive medicine.
Main Methods:
- Literature review focusing on Adenovirus (Ad) vector systems.
- Analysis of Ad vector capabilities for high-level heterologous gene expression.
- Evaluation of Ad vector suitability for therapeutic and vaccine applications.
Main Results:
- Adenovirus (Ad) vectors are effective tools for high-level gene expression.
- Ad vectors demonstrate potential for both therapeutic applications and vaccine development.
- Obstacles exist concerning the use of Ad vectors in preventive medicine.
Conclusions:
- Adenovirus (Ad) vectors are promising for gene therapy and vaccine development.
- Further research is needed to overcome challenges for Ad vector application in preventive medicine.
- Ad vectors represent a significant advancement in genetic engineering for medical applications.